Brokerages Set Express Scripts Holding Company (NASDAQ:ESRX) Price Target at $70.11

Shares of Express Scripts Holding Company (NASDAQ:ESRX) have been given a consensus recommendation of “Hold” by the twenty-four analysts that are currently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $70.18.

Several equities analysts recently weighed in on ESRX shares. Robert W. Baird cut their target price on shares of Express Scripts Holding from $73.00 to $53.00 and set a “neutral” rating for the company in a research note on Tuesday, April 25th. Morgan Stanley cut their target price on shares of Express Scripts Holding from $71.00 to $52.00 and set an “underweight” rating for the company in a research note on Wednesday, April 26th. SunTrust Banks, Inc. reaffirmed a “buy” rating on shares of Express Scripts Holding in a research note on Tuesday, April 25th. Cowen and Company cut their target price on shares of Express Scripts Holding from $90.00 to $83.00 and set an “outperform” rating for the company in a research note on Tuesday, April 25th. Finally, Edward Jones cut shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Wednesday, April 26th.

Shares of Express Scripts Holding (NASDAQ ESRX) traded up 0.91% on Tuesday, hitting $62.90. The stock had a trading volume of 3,038,852 shares. The firm has a 50-day moving average of $63.12 and a 200 day moving average of $65.16. Express Scripts Holding has a 1-year low of $57.80 and a 1-year high of $77.61. The company has a market capitalization of $36.33 billion, a PE ratio of 10.92 and a beta of 0.90.

Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.02. The firm had revenue of $25.35 billion for the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The company’s revenue was up .5% on a year-over-year basis. During the same period last year, the firm earned $1.57 EPS. On average, equities analysts anticipate that Express Scripts Holding will post $7.01 earnings per share for the current fiscal year.

In related news, VP Phyllis S. Anderson sold 1,100 shares of Express Scripts Holding stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the sale, the vice president now owns 11,108 shares in the company, valued at approximately $667,368.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.68% of the company’s stock.

Several large investors have recently bought and sold shares of ESRX. Dodge & Cox acquired a new stake in Express Scripts Holding during the fourth quarter valued at approximately $1,456,850,000. Cigna Investments Inc. New acquired a new stake in Express Scripts Holding during the fourth quarter valued at approximately $1,593,000. Highbridge Capital Management LLC raised its stake in Express Scripts Holding by 1,476.0% in the fourth quarter. Highbridge Capital Management LLC now owns 423,411 shares of the company’s stock valued at $29,127,000 after buying an additional 396,544 shares in the last quarter. Hancock Holding Co. raised its stake in Express Scripts Holding by 9.9% in the first quarter. Hancock Holding Co. now owns 183,489 shares of the company’s stock valued at $12,094,000 after buying an additional 16,536 shares in the last quarter. Finally, Twin Capital Management Inc. raised its stake in Express Scripts Holding by 0.8% in the first quarter. Twin Capital Management Inc. now owns 46,560 shares of the company’s stock valued at $3,069,000 after buying an additional 360 shares in the last quarter. Institutional investors and hedge funds own 88.38% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Brokerages Set Express Scripts Holding Company (NASDAQ:ESRX) Price Target at $70.11” was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark law. The original version of this report can be accessed at https://www.chaffeybreeze.com/2017/07/29/express-scripts-holding-company-nasdaqesrx-given-average-rating-of-hold-by-brokerages-updated-updated-updated.html.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply